tem." 10 The Joint Commission recognizes the importance of medication reconciliation, at the same time acknowledging challenges in its implementation. 11 Pharmacists are well suited to improve medication safety, during both hospitalization and the transition from hospital to home. 12 Adding clinical pharmacist services to inpatient care, particularly by documenting patient medication histories, participating in patient rounds, performing medication reconciliation, or providing discharge counseling and follow-up has been shown to improve patient satisfaction as well as in-hospital and postdischarge outcomes. [12] [13] [14] [15] To our knowledge, no research has captured pharmacists' perspectives on their involvement in improving care transitions. We present a qualitative evaluation of pharmacists' experiences in the Pharmacist Intervention for Low Literacy in Cardiovascular Disease (PILL-CVD) study, a 2site, randomized trial to reduce serious medication errors after hospital discharge. 16 Through this qualitative evaluation, we sought to (1) examine the key experiences and perspectives of pharmacists about the delivery of care transition interventions; (2) determine differences and similarities in pharmacists' experiences implementing the intervention; and (3) identify recommendations for future care transition interventions. These pharmacists' perspectives offer insights into how to improve care transitions in general and how best to engage pharmacists in patient counseling, medication reconciliation, and patient follow-up after discharge.
Methods
Semistructured one-on-one interviews were completed with the PILL-CVD study pharmacists at 2 academic hospitals-Vanderbilt University Hospital (VUH) and Brigham and Women's Hospital (BWH). Participants at both sites were asked to elicit their perspectives on the intervention components and pharmacists' roles in improving care transitions.
OVERVIEW OF THE PILL-CVD INTERVENTION
Study participants (N = 851) were adults admitted with acute coronary syndromes or acute decompensated heart failure. Patients who did not manage their own medications or who were not expected to be discharged to home were excluded. During enrollment, participants completed measures of health literacy 17 and cognitive function, 18 the results of which were provided to study pharmacists for intervention patients. A complete description of the patient eligibility criteria, study design, and procedures has been reported. 16 PILL-CVD participants were randomized to receive usual care or an intervention that consisted of (1) pharmacist-assisted medication reconciliation at admission and discharge, (2) pharmacist-led counseling early in the hospi-talization, (3) pharmacist-led discharge counseling, and (4) a 1-to 4-day follow-up telephone call conducted by the study coordinator, with subsequent pharmacist follow-up if warranted. 15, 16 Prior to implementing the intervention, pharmacists participated in training sessions that reviewed best practices for obtaining a medication history, performing medication reconciliation, and counseling patients. 19 They also received individualized feedback on their counseling techniques and were required to demonstrate competency.
During the study, pharmacists followed protocols to help ensure consistency of intervention delivery. For medication reconciliation, they compiled a thorough medication history from multiple sources at the time of admission, alerted the treating physicians about any clinically relevant discrepancies, and performed reconciliation of discharge medications at the time of discharge. The initial counseling session, which usually overlapped with obtaining the admission medication history, provided pharmacists an opportunity to assess patients' understanding of the preadmission medication regimen, understanding of prescription drug labels, level of adherence, barriers to medication management, and social supports. During the discharge session, pharmacists provided counseling that was tailored to patients' needs and the discharge regimen prescribed by the treating physicians, using strategies for clear health communication, such as teach-back. At that time, pharmacists provided patients with an illustrated medication schedule that depicted their daily regimen in a simple format and offered a pill box. After discharge, a research coordinator telephoned patients and followed a structured interview to screen for medication-related problems and to determine which patients needed to receive a follow-up telephone call by a pharmacist (eg, to address discrepancies, nonadherence, ADEs).
QUALITATIVE EVALUATION
To understand pharmacists' experiences of delivering a care transitions intervention, 1 author (AO) conducted oneon-one in-person interviews with study pharmacists (n = 11). This qualitative approach allowed us to explore pharmacists' views and probe for their recommendations. To guide the interviews, 2 authors (KTH, AO) developed a semistructured manual that provided clear aims and questions for data collection, with provisions for following up on participants' responses (Appendix I, available at www.hwbooks.com/pdf/appendices/Q641.pdf). The interview guide focused on the PILL-CVD intervention components and followed an expanded version of the RE-AIM (Reach, Efficacy, Adoption, Implementation, Maintenance) evaluation framework that was developed for this study. 20 Pharmacists were asked about their training to deliver the intervention, the implementation and effectiveness of the intervention, how it fit within their roles, and suggestions to improve delivery of care transition interventions in general. They also were asked about any lasting changes in their approach to patient assessment and counseling as a result of their involvement in this initiative. Follow-up probes, both planned and spontaneous, were used to clarify responses.
Pharmacists provided written informed consent to be interviewed and audio recorded. Interviews were transcribed using Express Scribe (version 5.04) online transcription software. Pharmacists' names were converted to pseudonyms during transcription.
Transcripts were analyzed using NVivo, a qualitative data analysis software program. 21 Coding was based in the RE-AIM evaluation framework, focusing on the domains of efficacy, adoption, and implementation, and followed the structure of the interview guide. Emergent themes were incorporated as well. AO and KTH initially coded each transcript and then discussed and reconciled discrepant coding. AO wrote thematic analyses assessing the range of perspectives on each coding theme and variations within the themes. KTH reviewed and revised each thematic summary and compared themes across the 2 sites to gain deeper understanding of program implementation in each setting. Both authors culled illustrative quotes from the interview data to include in the thematic analyses. The thematic analyses were used to compile a summary document and executive summary of the findings from the pharmacist interviews, which served as the basis for this article.
Results
Interviews took place between April 1, 2010, and June 4, 2010, and ranged from 34 to 67 minutes. Results of the qualitative analysis are organized according to the major components of the intervention, followed by pharmacists' recommendations for improving care transitions.
INTERVENTION COMPONENTS

Medication Reconciliation
Pharmacists considered medication reconciliation to be the most important component of the multifaceted intervention and the most important way for pharmacists to engage in improving care transitions. Obtaining a complete medication history and reviewing medications with patients not only provided an opportunity to identify and correct errors in the patient's medical record, but also helped to avert potential ADEs. As one pharmacist noted, "You always find something on there that needs to be changed or clarified."
Pharmacists said that the accuracy of preadmission medication lists (PAMLs) documented by treating physi-cians varied for different reasons, including when and where the medication history was taken, whether the patient was fully alert at the time, and whether the patient or family had an updated medication list for reference. VUH pharmacists more often reported catching medication errors, compared with pharmacists at BWH, where, prior to the PILL-CVD study, pharmacists were already involved in medication reconciliation. No other differences between the 2 sites were noted by the pharmacists.
Participants reported using various means to develop accurate medication lists, including patient or family member recall, patients' home medication lists, reviewing the documented PAML again with patients, and contacting local pharmacies. One pharmacist indicated that medication reconciliation is "a big concern still and even after doing the study it makes me realize that much more how big of a problem it really is."
Pharmacists described other positive consequences of conducting detailed medication reconciliation including that it (1) helped clarify medication information for patients, (2) helped patients communicate with their physicians about the medications, and (3) improved the efficiency of ordering medications at discharge. Pharmacists also noted that, because the process of performing a detailed medication review identified patients' knowledge gaps, medication reconciliation also set the stage for tailored discharge counseling. One problem that pharmacists noted, however, was the amount of time required to adequately perform medication reconciliation.
Initial Counseling Session
Pharmacists reported that their patient counseling session early in the patient's hospitalization provided a valuable opportunity to gather background information and lay the groundwork for discharge counseling. Not only did pharmacists learn about patients' specific needs, but by getting patients to think about their medications, the initial counseling facilitated patient engagement in subsequent counseling. One pharmacist described the initial counseling session, saying it "helped make the discharge counseling more efficient." Another pharmacist commented, "initial counseling is always important because you find out from the patient what the patient is really taking even though you have this list of medications. Sometimes the patients don't really take that or they just don't take it appropriately, so it's always good to talk to the patient instead of just looking at the paper."
Pharmacists used a data collection form to guide the patient interview. This form promoted adherence to the study protocol and provided a place for pharmacists to document patients' understanding of the medication regimen, ability to comprehend a pill bottle label, medication adherence, barriers, and supports. Some pharmacists found the forms useful, while others noted that they were time-consuming or cumbersome.
Pharmacists reported that the most important question they asked patients in the initial counseling session was, "During the week before you were in the hospital, how many days did you miss taking one of your medicines?" This question was part of the counseling protocol and helped pharmacists identify and start to address nonadherence. Pharmacists also found it useful to show patients a sample pill bottle label to determine patients' comprehension of medication container labels. This, too, was part of the counseling protocol and helped pharmacists tailor their subsequent counseling.
Pharmacists reported that most patients were receptive to this counseling session, although barriers sometimes existed. Patient availability was an issue at both sites; patients were sometimes too tired to receive the initial counseling session, out of the room, or undergoing a procedure. Other times sessions were interrupted by other aspects of medical care, which led to piecemeal efforts to complete the initial counseling session. One pharmacist indicated that patients' mental status (eg, delirium) or use of pain medication limited patients' ability to participate and required the pharmacist to return at a later time. In general, pharmacists found that the initial counseling session allowed them to build rapport, motivate patients, establish an accurate medication list, and understand patients' barriers to medication use, all of which enhanced subsequent interactions and counseling. Pharmacists also took the opportunity to encourage family members to be present at the time of discharge to better assist the patient with handling medications upon returning home.
Discharge Counseling Session
Study pharmacists uniformly found that the discharge counseling session helped patients understand their new medication regimens. This counseling session, which occurred after the treating physician had written the prescriptions, included several components per the protocol: review of discharge medications, discussion of a plan for filling new prescriptions, anticipation and troubleshooting of barriers to adherence, provision of adherence aids, and teach-back to confirm understanding. One pharmacist reported that the "discharge was more of the meat [of the intervention] than the initial session." Another pharmacist relayed that she "had patients who took notes and [realized they had been] taking their medications wrongly for all their lives…." Problems with medication use that the patients relayed included they did not know that they had to take certain medications at a specified time or that they should not drink juice with certain medications.
Pharmacists reported that the in-depth review of discharge medications was the most beneficial component of the discharge counseling sessions. This review was facili-tated by provision of an illustrated medication schedule, which pharmacists prepared immediately before the session. 16, 22 The illustrated medication schedule showed the complete medication regimen with the indication, dose, frequency, main side effects, and any special instructions for each medication. Pharmacists used the schedule to review the discharge medication instructions, while highlighting changes compared with the preadmission regimen. Pharmacists thought that it was important to focus on such changes. One commented that "a lot of times, [patients] are taking the same drug, but the dosage has just been slightly modified and sometimes I feel like [that] information is usually not communicated as clearly as if you're starting a new drug."
Study pharmacists from both sites reported that it was sometimes challenging to determine whether patients needed a focused review versus a complete review of medications. The study protocol called for complete review with teach-back of key elements, but this appeared unnecessary for some patients. When many medications were prescribed, a complete review could be time consuming. Pharmacists, therefore, had mixed feelings about routine use of teach-back. Although most reported that they enjoyed using this technique and incorporated it effectively into their counseling, at times they thought that patients were not receptive to it or that it felt awkward. The latter occurred when patients either did not understand their medication regimen, in which case it could be frustrating, or when the patient understood it very well, in which case it seemed unnecessary.
Pharmacists reported other challenges when performing discharge counseling. First, time pressures were often palpable. Patients who were eager to leave the hospital quickly were less receptive to counseling and, at times, became frustrated. One pharmacist reported feeling pressured because of the hospital's desire to prepare the room for the next patient. As a result of such time pressures, pharmacists sometimes had to cut a session short, focusing on changes in the medication regimen. For example, 1 pharmacist reported that "we mostly got the key stuff in but just knowing that they're sitting there, you're frantically trying to get everything ready" [for them to be discharged]. Second, pharmacists sometimes suspected that patients did not ask as many questions as they should have, even though the pharmacists had been trained on how to effectively elicit questions from patients. 19 These issues notwithstanding, pharmacists regarded discharge counseling as important for patient health, even though patients and hospital staff sometimes perceived the discharge counseling session as slowing the discharge process.
Medication Management Tools
Pharmacists found that providing adherence aids was highly valuable for patients with low health literacy, but
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The Annals of Pharmacotherapy I 2012 September, Volume 46 I 1155 theannals.com less so for patients with adequate health literacy. As noted above, pharmacists provided patients with an illustrated medication schedule that facilitated discharge counseling by clearly depicting the name, indication, dose, frequency, main side effects, and special instructions for each medication. Patients were encouraged to keep the illustrated medication schedule in a visible location at home to promote adherence and to bring it to physicians' appointments to facilitate discussion about medications. While pharmacists believed that the illustrated medication schedule was an effective educational tool and reminder for patients, they noted that it was time consuming to produce. It was made from a template created in a common word processor, and for patients with a long medication list, could take 30-45 minutes to construct. This posed a challenge when patients were eager to leave the hospital. Pharmacists also noted that, optimally, a mechanism would exist to create the patient's illustrated medication schedule more quickly, as well as update it as medications changed.
Pharmacists also encouraged patients to use the illustrated medication schedule to help them prepare a pill box, which was offered to all intervention patients as an adherence aid. The pill box was welcomed by many patients. However, for patients who were reluctant to use one, pharmacists found it helpful to engage family members' help during discharge counseling.
Follow-up Call
Pharmacists were generally satisfied with the PILL-CVD model of having non-health care professionals conduct the initial postdischarge follow-up telephone calls, which used a scripted interview to identify medication-related issues and any new or worsening symptoms. The study coordinator determined whether a follow-up telephone call with a pharmacist was warranted based on whether the patient was experiencing medication-related issues. This model proved relatively efficient, as approximately 60% of patients did not have issues requiring pharmacist involvement and, among those who did, pharmacists could focus on the issue at hand rather than performing a full review.
Nevertheless, some pharmacists noted that they would have preferred to conduct follow-up telephone calls personally, without the intermediate step. Also, while the timing of patient discharge did not always allow the same pharmacist to monitor each patient from admission to discharge and the follow-up telephone call, when continuity was maintained, pharmacists said that the rapport established during the counseling sessions increased the likelihood of patients' raising and discussing any medication issues with them during follow-up. They agreed, however, that a pharmacist-led model for postdischarge telephone follow-up in most settings would be time and cost prohibitive.
PHARMACISTS' RECOMMENDATIONS TO IMPROVE
HOSPITAL DISCHARGE PROCEDURES
Based on their experiences, pharmacists provided many suggestions to improve the general coordination of care and quality of hospital discharge. Their recommendations related to multidisciplinary communication, handling of discharge prescriptions, protecting time for discharge counseling, optimizing patient and family engagement in discharge counseling, and providing patient education materials (Table 1) .
Discussion
In this qualitative study of pharmacists who delivered a care transition intervention, we identified strengths and weaknesses of the particular intervention, as well as several valuable suggestions to improve the discharge process in general.
All aspects of the PILL-CVD intervention were thought to be valuable, although pharmacists identified medication reconciliation as the most important component and the most impactful area for their involvement. Discharge counseling was also a critical time to review medication instructions, focusing on new medications and changes to the patient's regimen. Discharge counseling was aided by the use of a simple, illustrated medication schedule, although the schedule presented challenges in terms of preparation and presentation time pressures.
By teaching patients to use medication management tools, pharmacists were involved in promoting patient selfmanagement behaviors. Pharmacists' varying perceptions of patients' receptivity to and need for teach-back suggests the need to customize the teach-back to the patient's health literacy and medication understanding. For those who understood their medication regimens readily, pharmacists could truncate the teach-back, while for those who needed greater explanation, the teach-back could be more thorough.
By participating in the hospital discharge and follow-up of more than 400 patients in the PILL-CVD study, pharmacists developed insights to aid them in improving the care transition process in general (Table 1 ). These included, for example, improving communication about the anticipated time of discharge, scheduling time for discharge counseling, and building rapport with patients so as to motivate them and promote their active participation during discharge counseling.
These results are consistent with and add to the lessons learned from other interventions that were designed to improve the transition from hospital to home. In evaluating implementation of the Care Transition Intervention, Coleman and colleagues learned that patients often had poor understanding of their medications at the time of discharge and suggested greater involvement by hospital clinical staff and pharmacists. 23 At the University of Michigan, a pharmacistfacilitated discharge program improved the quality of hospital discharge, largely through the pharmacist's performance of medication reconciliation, although this was noted to be very time consuming. 24 Project RED investigators at Boston University found that the discharge process was strengthened when planned for in advance and when illustrated, patient-centered discharge instructions were used. 13 Limitations of this study include its reliance on perspectives of pharmacists from 2 academic hospitals; it does not represent pharmacists' views broadly and has limited generalizability. The participants' comments were based primarily on their experiences implementing the PILL-CVD intervention and did not address other roles that pharmacists may play, such as promoting guideline-based prescribing or recommending cessation of potentially inappropriate medications.
These limitations notwithstanding, this study enhances understanding of the value of pharmacist-delivered care transition interventions, providing pharmacists' insights for improving hospital discharge transitions and highlighting some of the important roles that pharmacists can play in this process. Notably, pharmacists were involved in cognitively demanding functions that included assessing patients' understanding and barriers to adherence; building rapport with and motivating patients; and tailoring patient counseling to specific situations and barriers, such as low health literacy or cognitive impairment. We hope that this hypothesis-generating study will stimulate additional research to better define pharmacists' optimal role in care transitions, including the feasibility and cost-effectiveness of different approaches, and in different settings. La implementación en hospitales de programas multifacéticos para mejorar la reconciliación de medicamentos y la transición del cuidado, en muchas ocasiones involucrando los farmacéuticos, ha ido en aumento.
OBJETIVO: Evaluar la visión del farmacéutico sobre su papel en la reconciliación de medicamentos en el hospital y la consejería al alta y proveer sus recomendaciones para mejorar la transición del cuidado.
MÉTODOS:
Once farmacéuticos en 2 hospitales participaron en el estudio Intervención del Farmacéutico para la Literacia Baja en Enfermedad Cardiovascular (PILL-CV) y completaron entrevistas semiestructuradas realizadas uno-a-uno, las cuales fueron codificadas sistemáticamente en NVivo. Los farmacéuticos proveyeron sus perspectivas en cuanto a la reconciliación de medicamentos en la admisión y al alta, la consejería a pacientes en el hospital, la provisión de ayudas simples de adherencia a los medicamentos (ej, pastilleros, itinerarios ilustrados de medicamentos) y seguimiento por teléfono.
RESULTADOS:
Los farmacéuticos indicaron que ellos consideran que la reconciliación de medicamentos, aunque consume mucho tiempo, es su papel más importante para mejorar la transición del cuidado, particularmente por la detección de errores que requieren corrección en el historial de medicamento en la admisión. También identificaron pacientes que requirieron consejería adicional debido al poco entendimiento sobre sus medicamentos. Los farmacéuticos entendieron que el proveer ayudas de adherencia es de mucho valor para los pacientes con literacia de salud baja, aunque de menor valor para los pacientes con literacia de salud adecuada. Los farmacéuticos notaron que el tener personal administrativo adiestrado para conducir llamadas de seguimiento temprano después del alta para cernir asuntos y pacientes que requieren la intervención del farmacéutico fue de ayuda y una utilización eficiente de recursos. Las recomendaciones de los farmacéuticos para mejorar la transición del cuidado incluyó una comunicación clara entre los miembros del equipo, tiempo protegido para la consejería al alta, participación del paciente y familiares en la consejería al alta, y la provisión de materiales de educación a pacientes.
CONCLUSIONES: Los farmacéuticos están bien posicionados para participar en la reconciliación de medicamentos en los hospitales, identificar pacientes con poco entendimiento sobre los medicamentos o adherencia pobre, y proveer consejería individualizada para mejorar la transición del cuidado. Se necesitan estudios adicionales para confirmar estos hallazgos en otros escenarios y para determinar la eficacia y costo-efectividad de los diferentes modelos de participación del farmacéutico. OBJECTIF: Évaluer l'opinion des pharmaciens quant à leurs rôles dans le bilan comparatif des médicaments à l'hôpital, les conseils au patient au congé de l'hôpital, et faire des recommandations pour améliorer la continuité des soins.
MÉTHODES:
Onze pharmaciens travaillant dans 2 hôpitaux ont participé à l'étude intervention du pharmacien pour un faible taux d'alphabétisation en maladie cardiovasculaire (PILL-CVD). Ils ont complété des entrevues semi structurées individuelles qui étaient codifiées de manière systématique en utilisant NVivo. Les pharmaciens ont décrit leurs perspectives sur le processus d'admission et de congé, le bilan comparatif, la remise de conseils aux patients hospitalisés, l'aide à la prise des médicaments et les suivis téléphoniques. RÉSULTATS: Les pharmaciens ont indiqué qu'ils considéraient que le bilan comparatif, bien qu'il prenne beaucoup de temps, représente un élément important dans l'amélioration de la continuité des soins, spécifiquement par la détection d'erreurs qui sont corrigées dans l'histoire médicamenteuse à l'admission. Ils ont aussi identifié les patients qui avaient besoin d'informations supplémentaires puisqu'ils avaient une mauvaise compréhension de leurs médicaments. La mise en place d'aide à la prise des médicaments était considérée comme étant très utilisée chez les patients ayant un faible taux d'alphabétisation. Les pharmaciens ont également précisé qu'avoir accès à du personnel administratif bien formé pour effectuer les appels de suivi suite au congé de l'hôpital s'est avéré très utile. Les recommandations des pharmaciens pour améliorer la continuité de soins comprenaient une bonne communication entre les membres de l'équipe, du temps protégé pour effectuer les conseils de départ et la remise de matériel éducatif pour les patients.
CONCLUSIONS:
Les pharmaciens sont bien positionnés pour participer au processus de bilan comparatif, identifier les patients qui ont une mauvaise compréhension de leurs médicaments et offrir des conseils adaptés aux patients pour améliorer la continuité des soins. Des études supplémentaires sont nécessaires pour confirmer ces données dans d'autres unités de soins et de déterminer l'efficacité et le rapport coût efficacité des différents modèles d'implication du pharmacien.
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